Skip to main content

Mortality in Rheumatic Heart Disease Is High

Medically reviewed by Carmen Pope, BPharm. Last updated on June 7, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June 5 in the Journal of the American Medical Association.

Ganesan Karthikeyan, D.M., from the All India Institute of Medical Sciences in New Delhi, and colleagues assessed the risk and predictors of major patient-important clinical outcomes in patients with clinical RHD. Analysis included 13,696 patients in 24 low- and middle-income countries.

The researchers found that over a median duration of 3.2 years, 15 percent of patients died overall (4.7 percent per patient-year). Vascular causes accounted for most deaths (67.5 percent), mainly heart failure or sudden cardiac death. Both stroke (0.6 percent per year) and recurrent rheumatic fever was rare. Higher mortality was seen with markers of severe valve disease, including congestive heart failure (hazard ratio [HR], 1.58), pulmonary hypertension (HR, 1.52), and atrial fibrillation (HR, 1.30). Lower mortality was seen with surgical treatment (HR, 0.23) or valvuloplasty (HR, 0.24). Lower mortality was also seen with higher country income level, when adjusting for patient-level factors.

"Study findings suggest a greater need to improve access to surgical and interventional care, in addition to the current approaches focused on antibiotic prophylaxis and anticoagulation," the authors write.

Several authors disclosed ties to pharmaceutical companies, including Bayer, which funded the study.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted June 2024

Read this next

AGA Finds No Clear Evidence for or Against AI-Assisted Colonoscopy

WEDNESDAY, April 2, 2025 -- In a living clinical practice guideline issued by the American Gastroenterological Association and published in the April issue of Gastroenterology, no...

Similar Mortality Benefit Seen for Concentrated, Evenly Spread Physical Activity

WEDNESDAY, April 2, 2025 -- Engaging in physical activity concentrated within one to two days is associated with a similar reduction in mortality risk as active regular physical...

At-Home Smell Test Can Help ID Risk for Cognitive Impairment

WEDNESDAY, April 2, 2025 -- The digital remote AROMHA Brain Health Test (ABHT) can discriminate cognitively normal (CN) older adults from those with cognitive impairment...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.